Exosome Diagnostic and Therapeutic Market Trends 2023: Predicted to Surpass USD 2.9 Billion by the year 2030, Claims AMR

What is the market for exosome diagnostics and therapeutics?

According to the report, the global exosome diagnostic and therapeutic industry was estimated at $224.34 million in 2020, and is anticipated to hit $2.9 billion by 2030, registering a CAGR of 29.4% from 2021 to 2030.

Key Takeaways:

• Diagnostic Potential:
  • Exosomes have garnered significant interest as potential diagnostic markers due to their ability to carry specific molecules derived from diseased cells, providing a non-invasive way to access valuable diagnostic information.
  • Researchers have explored the potential of exosomes as biomarkers for various diseases, including cancer, neurodegenerative disorders, cardiovascular diseases, and infectious diseases. The unique molecular cargo of exosomes can offer insights into disease progression and response to treatment.
• Liquid Biopsies:
  • Exosomes offer a promising avenue for liquid biopsy techniques, enabling the detection and monitoring of diseases through a simple blood or other bodily fluid sample. This can reduce the need for invasive tissue biopsies.
  • In the field of oncology, exosome-based liquid biopsies have the potential to revolutionize cancer diagnosis, prognosis, and treatment monitoring by providing real-time information about tumor mutations and treatment resistance.
• Therapeutic Applications:
  • Exosomes are being investigated as potential therapeutic vehicles for drug delivery due to their natural ability to transport biological cargo across cell membranes.
  • Scientists are exploring exosome-based therapies for conditions such as cancer, neurodegenerative diseases, and tissue regeneration. Exosomes can be engineered to carry specific therapeutic molecules and target specific cells or tissues.

Request Sample Copy of the Report: 

https://www.alliedmarketresearch.com/request-sample/1723

Covid-19 scenario-

• Rapid spread of Covid-19 heightened the need for molecular diagnosis, thus impacting the global exosome diagnostic and therapeutic market positively.
• This trend is pretty likely to continue till the pandemic is completely over.

  Exosome Diagnostic And Therapeutic Market Scope:

Market Segmentation:

By Application:

• • Diagnostics: This includes segments such as cancer diagnostics, cardiovascular disease diagnostics, neurodegenerative disease diagnostics, infectious disease diagnostics, and more. Exosomes’ ability to carry disease-specific biomarkers has led to the development of tests for early detection, prognosis, and monitoring of various diseases.
  • Therapeutics: Segments might include cancer therapeutics, regenerative medicine, neurological therapeutics, and more. Exosomes can be engineered to deliver therapeutic molecules, such as drugs, RNA, and proteins, to target cells or tissues.

By Source:

• • Human Cells: Exosomes can be derived from various human cell types, such as blood cells, stem cells, and cancer cells. Different sources may have distinct cargo profiles that can be utilized for specific applications.
  • Other Biological Sources: In addition to human cells, exosomes can be isolated from other biological sources like plants, animals, and microorganisms. These alternative sources have their own unique cargo and potential applications.

By Isolation Method:

• • Ultracentrifugation: Traditional method involving high-speed centrifugation to separate exosomes from other cellular components.
  • Filtration: Using various pore-size filters to isolate exosomes based on size.
  • Precipitation: Chemical reagents are used to precipitate exosomes from a sample.
  • Microfluidics: Lab-on-a-chip devices that use microfluidic technology to isolate and analyze exosomes.
  • Immunocapture: Antibodies specific to exosomal markers are used to capture exosomes.

By End User:

• • Research and Academic Institutes: These institutions play a significant role in advancing the understanding of exosome biology, cargo, and potential applications.
  • Pharmaceutical and Biotechnology Companies: These companies are involved in the development of exosome-based diagnostics and therapeutics, as well as commercialization.
  • Hospitals and Clinics: Clinical applications of exosomes include diagnostic tests and potential therapeutic interventions.

By Region:

• North America  (U.S., Canada, Mexico)
• Europe  (Germany, France, U.K., Italy, Spain, Rest of Europe)
• Asia-Pacific  (Japan, China, Rest of Asia-Pacific)
• LAMEA  (Brazil, Saudi Arabia, South Africa, Rest of LAMEA)

Request for Customization – 

https://www.alliedmarketresearch.com/request-for-customization/1723

Regional Growth Dynamics:

North American accounted 28.6% of the share in the  market from 2021 to 2030, and is expected to maintain this leading position throughout the forecast period. The growth in the exosome diagnostic and therapeutic market in the region is attributed to the technological advancement in the isolation of exosomes, innovative and advanced applications of exosome-based products, and geriatric population coupled with increasing incidence of diseases, such as cancer and cardiovascular diseases. However, Asia-Pacific is projected to be the fastest-growing region, registering a CAGR of 30.3% during the exosome diagnostic and therapeutic market forecast period.

Competitive Landscape:

• Exosome Diagnostics Inc.
• NanoSomix Inc.
• Thermo Fisher Scientific Inc.
• Malvern Instruments Ltd.
• System Biosciences Inc.
• NX Pharmagen
• Aethlon Medical, Inc.
• Sistemic Inc.

Table of Content:

• CHAPTER 1: INTRODUCTION
  • 1.1. Report description
  • 1.2. Key market segments
  • 1.3. Key benefits to the stakeholders
  • 1.4. Research Methodology
    • 1.4.1. Primary research
    • 1.4.2. Secondary research
    • 1.4.3. Analyst tools and models

• CHAPTER 2: EXECUTIVE SUMMARY
  • 2.1. CXO Perspective

• CHAPTER 3: MARKET OVERVIEW
  • 3.1. Market definition and scope
  • 3.2. Key findings
    • 3.2.1. Top impacting factors
    • 3.2.2. Top investment pockets
  • 3.3. Porter’s five forces analysis
    • 3.3.1. Low bargaining power of suppliers
    • 3.3.2. Low threat of new entrants
    • 3.3.3. Low threat of substitutes
    • 3.3.4. Low intensity of rivalry
    • 3.3.5. Low bargaining power of buyers

Buy this Premium Research Report: 

https://www.alliedmarketresearch.com/purchase-enquiry/1723

VALUE PROPOSITIONS RELATED TO THE REPORT:

• Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
• Comprehensive quantitative and qualitative insights at segment and sub-segment level
• Covid 19 impact trends and perspective
• Granular insights at global/regional/country level
• Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment

Contact Details:

David Correa
USA/Canada (Toll-Free): +1-800-792-5285, +1-503-894-6022
help@alliedmarketresearch.com

About Us

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.